Skip to main content
Douglas Galasko, MD, Neurology, La Jolla, CA

Douglas R Galasko MD


Professor, Neurosciences, UCSD School of Medicine Director of the UCSD Shiley-Marcos Alzheimer's Disease Research Center (ADRC).

Join to View Full Profile
  • 9350 Campus Point DrPerlman Ambulatory Care Center - NeurologyLa Jolla, CA 92037

  • Phone+1 858-657-8540

  • Fax+1 858-657-8557

Dr. Galasko is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Neurology, 1984 - 1987
  • Boston University Medical Center
    Boston University Medical CenterInternship, Internal Medicine, 1983 - 1984
  • University of the Witwatersrand
    University of the WitwatersrandClass of 1979

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1988 - 2026
  • MD State Medical License
    MD State Medical License 1985 - 1988
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Comprehensive Screening of Copy Number Variability in Dementia with Lewy Bodies  
    Eliezer Masliah, Ted Dawson, Nigel J Cairns, John C Morris, Sonja W Scholz, John Q Trojanowski, Liana Rosenthal, Lawrence S Honig, Douglas Galasko, Thomas G Beach, Ron..., ScienceDirect
  • Microstructural Brain Changes Track Cognitive Decline in Mild Cognitive Impairment  
    James B Brewer, Christina E Wierenga, Douglas Galasko, ScienceDirect

Lectures

  • 14th International Conference on Alzheimer's Drug Discovery 
    Alzheimer's Drug Discovery Foundation, Jersey City, New Jersey - 9/9/2013

Press Mentions

  • Biomarker Test Can Detect Alzheimer's Pathology Earlier
    Biomarker Test Can Detect Alzheimer's Pathology EarlierFebruary 10th, 2025
  • New Biomarker Test Detects Early Tau Tangles in Alzheimer's Disease
    New Biomarker Test Detects Early Tau Tangles in Alzheimer's DiseaseFebruary 9th, 2025
  • New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in the Blood – Neuroscience News
    New Biomarker Test Can Detect Alzheimer’s Neurodegeneration in the Blood – Neuroscience NewsDecember 29th, 2022
  • Join now to see all

Grant Support

  • Dementia with Lewy Bodies ConsortiumCLEVELAND CLINIC LERNER COM-CWRU2016–2027
  • Dementia with Lewy Bodies ConsortiumCLEVELAND CLINIC LERNER COM-CWRU2016–2027
  • Comparative Study of Molecular Signatures in HIV-Related Neuropathogenesis and Alzheimer's DiseaseUNIVERSITY OF CALIFORNIA, SAN DIEGO2018–2025
  • Clinical Core BNational Institute On Aging2009–2012
  • Administrative Core ANational Institute On Aging2009–2012
  • Alzheimer'S Disease Research CenterNational Institute On Aging2007–2012
  • Clinical Studies Of Nsaidss As Y-Secretase Modulators In Alzheimer'S DiseaseNational Institute On Aging2009–2011
  • A Trial Of Ttp488 To Slow The Rate Of Clinical Progression Of Patients With ADNational Institute On Aging2006–2010
  • Testing The Role Of Axonal Transport Disturbance In AD?National Institute On Aging2007–2008
  • Biomarkers In Aging, MCI And Alzheimer'S DiseaseNational Institute On Aging2003–2007
  • Age Related Neurodegenerative Diseases In MicronesiaNational Institute On Aging2000–2006
  • Prevalence /Incidence /Risk Factors For Dementia On GuamNational Institute On Aging2002
  • Core--ClinicalNational Institute On Aging2002
  • Core---Administrative, Database, And StatisticalNational Institute On Aging2002
  • Clinical Evaluation Of Nsaids As Anti-Amyloid CompoundsNational Institute On Aging2002
  • A Phase 1B Study Of Ipa In ADNational Institute On Aging2001–2002

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: